Combining medical research and cosmetology, Vivaligne is recognized as ‘the Age Specialist’.
Vivaligne, with the support of its R&D Centre Regentis-Pharma, in the Faculty of Medicine, Reims has developped partnerships with university and hospital partners, to keep innovating to preserve the youthfulness and beauty of the skin.
Our
R&D CENTRE : REGENTIS-PHARMA
RESEARCH OF INNOVATIVE TREATMENTS IN THE FIELD OF TISSUE REGENERATION TO ENHANCE ITS EFFICACY
Vivaligne’s R&D centre, Regentis-Pharma, is a start-up company in the Medical Faculty of Reims. This innovative biotechnology company focuses its research on an ambitious mission : to repair and regenerate tissue.
The Regentis-Pharma scientific team focuses strategically on identifying and developing new synthetic, or natural bifunctional/trifunctional peptides, to market cosmetic products, medical devices and treatments.
Regentis-Pharma’s mission is to develop innovative curative treatments, to repair and regenerate tissue. This mission has many areas of practical application:
- Dermocosmetics (cutaneous ageing)
- Healing curative processes (victims of severe burns,…)
- Periodontal disease
- Bone regeneration
- Cardiovascular disease